Evidence map›Paper›PMID 23486207›Full record

ArticleJournal of neurophysiology2013

The μ-opioid receptor agonist DAMGO presynaptically suppresses solitary tract-evoked input to neurons in the rostral solitary nucleus.

Alison J Boxwell, Yuchio Yanagawa, Susan P Travers, Joseph B Travers

Open access · greenAbstract read
In one paragraph

Article in Journal of neurophysiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Alcohol and Opioids Modulate Excitatory Inputs to the SCN.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Enhancing GABAergic Tone in the Rostral Nucleus of the Solitary Tract Reconfigures Sensorimotor Neural Activity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alison J BoxwellDivision of Oral Biology, College of Dentistry, The Ohio State University, Columbus, Ohio 43210, USA. alison.boxwell@osumc.edu
Yuchio Yanagawa
Susan P Travers
Joseph B Travers
The Ohio State University · USJapan Science and Technology Agency · JP

Funding

Comprehensive Training in Oral &Craniofacial SciencesT32DE014320 · NIDCR · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2001 to 2022
$10.2M
GUSTATORY AFFERENT ORGANIZATION IN THE SOLITARY NUCLEUSR01DC000416 · NIDCD · OHIO STATE UNIVERSITY · PI TRAVERS, SUSAN P · 1992 to 2013
$2.7M
NEURAL BASIS OF TASTE ELICITED INGESTION AND REJECTIONR01DC000417 · NIDCD · OHIO STATE UNIVERSITY · PI TRAVERS, JOSEPH B · 1989 to 2009
$2.2M
ACOUSTIC PROCESSING IN THE HUMAN FRONTAL LOBEF32DC000417 · NIDCD · UNIVERSITY OF IOWA · PI BAKKEN, HANS E · 1999 to 2001
$19k
OLFACTORY BULB CIRCUIT ANALYSISF33DC000416 · NIDCD · YALE UNIVERSITY · PI MEREDITH, MICHAEL · 1999 to 2000
$4k
GUSTATORY AFFERENT ORGANIZATION IN THE SOLITARY NUCLEUSR29DC000416 · NIDCD · OHIO STATE UNIVERSITY · PI TRAVERS, SUSAN P · 1988 to 1990
–
NIDCD NIH HHS DC-00416NIDCD NIH HHS DC-00417NIDCD NIH HHS F32 DC000417NIDCD NIH HHS F33 DC000416NIDCD NIH HHS R01 DC000416NIDCD NIH HHS R01 DC000417NIDCR NIH HHS DE 014320NIDCR NIH HHS T32 DE014320
6 · The paper itself

Abstract

Taste processing in the rostral nucleus of the solitary tract (rNST) is subject to modulatory influences including opioid peptides. Behavioral pharmacological studies suggest an influence of μ-opioid receptors in rNST, but the underlying mechanism is unknown. To determine the cellular site of action, we tested the effects of the μ-opioid receptor agonist DAMGO in vitro. Whole cell patch-clamp recordings were made in brain stem slices from GAD67-GFP knockin mice expressing enhanced green fluorescent protein (EGFP) under the control of the endogenous promoter for GAD67, a synthetic enzyme for GABA. Neuron counts showed that ∼36% of rNST neurons express GABA. We recorded monosynaptic solitary tract (ST)-evoked currents (jitter ≤ 300 μs) in both GAD67-EGFP-positive (GAD67+) and GAD67-EGFP-negative (GAD67-) neurons with equal frequency (25/31; 22/28), but the inputs to the GAD67+ neurons had significantly smaller paired-pulse ratios compared with GAD67- neurons. DAMGO (0.3 μM) significantly suppressed ST-evoked currents in both cell types (mean suppression = 46 ± 3.3% SE), significantly increased the paired-pulse ratio of these currents, and reduced the frequency of spontaneous miniature excitatory postsynaptic currents but did not diminish their amplitude, indicating a presynaptic site of action. Under inhibitory amino acid receptor blockade, DAMGO was significantly more suppressive in GAD67+ neurons (59% reduction) compared with GAD67- neurons (35% reduction), while the reverse was true in normal artificial cerebrospinal fluid (GAD67+: 35% reduction; GAD67-: 57% reduction). These findings suggest that DAMGO suppresses activity in rNST neurons predominantly via a presynaptic mechanism, and that this effect may interact significantly with tonic or evoked inhibitory activity.

Indexed as

Evoked PotentialsNeural InhibitionAnimalsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-GABAergic NeuronsMiceMiniature Postsynaptic PotentialsNeurotransmitter AgentsReceptors, Opioid, muSolitary NucleusSynapsesEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Neurotransmitter AgentsReceptors, Opioid, mudisinhibitionGABAGAD67-GFP knockin mousetaste

Identifiers

PMID23486207
PMCPMC3680801
OpenAlexW2056347422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.